Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer

CD4(+) and CD8(+) T lymphocytes are powerful components of adaptive immunity, which essentially contribute to the elimination of tumors. Due to their cytotoxic capacity, T cells emerged as attractive candidates for specific immunotherapy of cancer. A promising approach is the genetic modification of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cartellieri, Marc, Bachmann, Michael, Feldmann, Anja, Bippes, Claudia, Stamova, Slava, Wehner, Rebekka, Temme, Achim, Schmitz, Marc
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864912/
https://www.ncbi.nlm.nih.gov/pubmed/20467460
http://dx.doi.org/10.1155/2010/956304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864912/
https://www.ncbi.nlm.nih.gov/pubmed/20467460
http://dx.doi.org/10.1155/2010/956304

Ejemplares similares